In its scientific opinion of 29 June 2022 [Scientific Opinion on Flavouring Group Evaluation 216 Revision 2 (FGE.216Rev2): consideration of the genotoxicity potential of α,β-unsaturated 2-phenyl-2-alkenals from subgroup 3.3 of FGE.19. EFSA Journal 2022;20(8):7420, doi:10.2903/j.efsa.2022.7420. Available online: https://www.efsa.europa.eu/en/efsajournal/pub/7420], the Authority evaluated the submitted data and concluded that the representative substance of the group, 2-Phenylcrotonaldehyde (FL No 05.062), induced an aneugenicity mode of action. As the available in vivo micronucleus studies were inconclusive, an in vivo potential aneugenicity cannot be ruled out for 2-Phenylcrotonaldehyde (FL No 05.062), 5-Methyl-2-phenylhex-2-enal (FL No 05.099) and 4-Methyl-2-phenylpent-2-enal (FL No 05.100).
Recital 6, Regulation (EU) 2024/238
In forcesince 15 Jan 2024